Point of Care (PoC) Diagnostics Market Size to Reach USD 60.67 Billion in 2028 – Reports and Data

Growing geriatric population worldwide and surging prevalence of diabetes and cardiovascular diseases are projected to drive market growth

The global point of care (PoC) diagnostics market size is expected to reach USD 60.67 billion by 2028 at a CAGR of 9.6%, according to a new report by Reports and Data. Growth in market revenue is attributed to rapidly growing geriatric population, increasing prevalence of target diseases worldwide, rising burden of infectious diseases such as COVID-19, and technological advancements in point of care diagnostic devices. Extensive use of point of care diagnostics for home healthcare, surging demand for rapid and accurate diagnostic results, increasing cases of COVID-19 worldwide, and rising volumes of molecular and antibody point of care diagnostic tests are the other major factors accountable for growth of the global point of care (PoC) diagnostics market.

Point of care diagnostic devices are widely used in healthcare facilities and home care settings to obtain diagnostic results of patients. These devices provide rapid feedback on various medical tests and allow healthcare professionals to achieve accurate, lab-quality diagnostic results in real-time. The key benefits of point of care diagnostics are rapid decision-making, reduced operating times, reduced post-operative care time, increased number of outpatient clinic visits, and lesser risks of antimicrobial contamination. This type of diagnostics helps doctors better diagnose and monitor a patient’s condition and their response to treatment.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1507

Some Key Highlights in the Report:

  • Based on product type, the cardiometabolic testing products segment accounted for the largest market value of USD 5411.7 million in 2020. Rising prevalence of cardiovascular disorders worldwide and increasing supply of cardiometabolic products are the primary factors driving the growth of this segment.
  • Based on platform, the molecular diagnostics segment is projected to register the highest CAGR over the forecast period. Growth of this segment is majorly supported by the COVID-19 outbreak, increasing volumes of COVID-19 tests, and technological advances in point of care molecular diagnostics products.
  • Based on prescription mode, the prescription-based testing segment, which held the largest market share in 2020, is expected to display the highest revenue growth rate during the forecast period.
  • Among the regional markets, the North America point of care (PoC) diagnostics market is expected to account for the largest market share of 41.1% over the forecast period, owing to growing prevalence of chronic and acute diseases, increasing cases of infectious diseases, emergence of advanced point of care diagnostic devices, and increasing FDA approvals for new products.
  • The Asia Pacific market is projected to register the fastest CAGR during the forecast period. Growing government investments in healthcare infrastructure development in the region and rise in strategic initiatives undertaken by the key market players in Asia Pacific are expected to drive the Asia Pacific market growth.
  • Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy are some of the key market players.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1507

For the purpose of this report, the global point of care (PoC) diagnostics market is segmented on the basis of product type, platform, prescription mode, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

  • Glucose Monitoring Products
    • Strips
    • Meters
    • Lancets & Lancing Devices
  • Cardiometabolic Testing Products
    • Cardiac Marker Testing Products
    • Blood Gas/Electrolytes Testing Products
    • HBA1C Testing Products
  • Infectious Disease Testing Products
    • Influenza Testing Products
    • HIV Testing Products
    • Hepatitis C Testing Products
    • Sexually Transmitted Disease (STD) Testing Products
    • Healthcare-Associated Infection (HAI) Testing Products
    • Respiratory Infection Testing Products
    • Tropical Disease Testing Products
    • Other Infectious Disease Testing Products
  • Coagulation Testing Products
  • PT/INR Testing Products
  • Activated Clotting Time (ACT/APTT) Testing Products
  • Pregnancy and Fertility Testing Products
  • Pregnancy Testing Products
  • Fertility Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Others

Platform Outlook (Revenue, USD Billion; 2018-2028)

  • Molecular Diagnostics
  • Agglutination assays
  • Biosensors
  • Dipsticks
  • Lateral Flow Assays
  • Microfluidics
  • Solid phase

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1507

Prescription Mode Outlook (Revenue, USD Billion; 2018-2028)

  • Prescription-based Testing
  • OTC Testing

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Hospitals/Critical Care Centers
  • Professional Diagnostic Centres
  • Outpatient Healthcare and Ambulatory Care Settings
  • Clinical Laboratories
  • Research Laboratories
  • Home Care
  • Others

Regional Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of the Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of the Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Healthcare Automatic Identification & Data Capture (AIDC) Market Size Share & Trends Analysis Report by Product Type (Hardware, Software & Services), by Application, by Region, Competitive Strategies and Segment Forecasts, 2018 – 2028       

Intraoperative Imaging (IOI) System Market By Type (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound), By Application Type (Hospitals, Academic Research Centres, Others), And Region-Global Forecast To 2027

Active Pharmaceutical Ingredients (API) Market By Type of Synthesis (Synthetic APIs, Biotech APIs), By Type of Manufacturer (Captive APIs, Merchant APIs), By Type (Generic APIs, Innovative APIs), By Application, By Region, And Segment Forecasts, 2016-2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-point-of-care-poc-diagnostics-market

Back to news